Modeling Risk Sharing Agreements and Patient Access Schemes

Gregory S. Zaric (), Hui Zhang and Reza Mahjoub
Additional contact information
Gregory S. Zaric: Western University
Hui Zhang: Lakehead University
Reza Mahjoub: Western University

Chapter Chapter 14 in Operations Research and Health Care Policy, 2013, pp 295-310 from Springer

Abstract: Abstract Risk sharing agreements are becoming an increasingly common type of contract between drug manufacturers and third party payers such as private insurance companies and public sector health plans. In a risk sharing agreement a payer will agree to include a drug on its formulary in the presence of a contract that reduces some of the payer’s risk. Payer risk may be caused by high uncertainty in sales volume, cost, effectiveness, or cost-effectiveness of a new drug. In this chapter we review the literature on risk sharing agreements, identify some opportunities for future research in the area, and highlight some policy implications associated with their use.

Keywords: National Health Service; Risk Sharing; Optimal Contract; Promotional Effort; Risedronic Acid (search for similar items in EconPapers)
Date: 2013
References: Add references at CitEc
Citations: View citations in EconPapers (2)

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:isochp:978-1-4614-6507-2_14

Ordering information: This item can be ordered from
http://www.springer.com/9781461465072

DOI: 10.1007/978-1-4614-6507-2_14

Access Statistics for this chapter

More chapters in International Series in Operations Research & Management Science from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().